Is Thymosin Alpha-1 Legal in Arizona? How to Access It Legally
HealthRX.com
No FDA approval or cleared compounding path in Arizona
Key numbers
- 4 yes and 17 noFDA advisory committee vote against adding thymosin alpha-1 to the compounding list, December 2024Source: fda.gov, as cited Nov 7, 2026
- 1.6 mgDose per injection on the Italian Zadaxin label; no US-approved dose existsSource: fda.gov, as cited Nov 7, 2026
- 4 weeksLength of the Italian Zadaxin course from the first vaccination; not a US-approved regimenSource: fda.gov, as cited Nov 7, 2026
At a glance
- FDA approval / None for any US indication [1]
- Orphan designations / Four, which are not approvals [1]
- State-licensed pharmacy list / In none of the three categories [2]
- Outsourcing facility list / Category 3, 'nominated without adequate support' [3]
- FDA advisory committee / Voted 4 yes, 17 no, December 2024 [4]
- HHS October 2026 peptide policy / Not among the six named peptides [5]
What is the federal position?
There is no approval to point to, and no FDA or HHS action we found permits this peptide to be compounded [1][5]. FDA proposed that thymosin alpha-1 not be added to the bulk substances list for state-licensed pharmacies, and its advisory committee voted against adding it [4]. The agency's category 1 policy does not apply to it [2][3].
Questions worth asking
Why FDA has held back
On December 4, 2024, FDA's Pharmacy Compounding Advisory Committee voted 4 yes and 17 no, with no abstentions, on both the free base and the acetate form; members who voted no cited no compelling evidence of clinical effectiveness and safety, and some who voted yes said patients should have access [4].
FDA's earlier review is still posted: a 'significant risk for immunogenicity for certain routes of administration', peptide-impurity and characterization problems, and safety information 'inadequate for the agency to sufficiently understand the extent of any safety issues' [6]. The substance moved to a 'nominated but withdrawn' table after the nominators withdrew it [6].
Where is it approved?
FDA lists national authorizations in Italy, where Zadaxin is authorized as an adjuvant to influenza vaccination in immunocompromised people; in India, for chronic hepatitis B in adults 18 or older with compensated liver disease and virus replication; and in Hong Kong [1]. The European Medicines Agency holds only an orphan designation for hepatocellular carcinoma, which is not a marketing approval [1].
What does the label say, and what did trials find?
No US-approved dose exists [1]. The Italian Zadaxin label gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks from the first vaccination, repeated week 8 to week 12 [1]. The label says not for children, contraindicated in pregnancy and breastfeeding, and calls for caution with allergies, autoimmune disease and other immune-modulating drugs [1].
FDA searched its adverse-event database on April 22, 2024 and found zero reports [1]. A 2026 Cochrane review of 10 randomized trials in 1349 adults with chronic hepatitis B found possibly fewer serious adverse events than comparison treatments (risk ratio 0.72, 95% CI 0.53 to 0.99; 5 trials, 1056 people; low-certainty evidence) and possibly lower all-cause mortality (RR 0.53, 95% CI 0.29 to 0.96; 3 trials, 907 people; very low certainty) [7]. Reviewers said they are 'not sure' it helps [7].
Is it banned in sport?
WADA's 2026 Prohibited List does not name thymosin alpha-1 [8]. It does name thymosin-beta-4 and derivatives such as TB-500 under S2.3, which are different peptides [8].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Is thymosin alpha-1 legal in Arizona?
Is thymosin alpha-1 FDA-approved?
Can it be compounded in the United States?
What does the Zadaxin label say?
Is it banned for athletes?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
Do you need a prescription for thymosin alpha 1?
Whether a prescription is required is not established. Thymosin alpha-1 is not FDA-approved in the United States, and FDA has not cleared it for compounding. It is approved as a medicine in Italy, India and Hong Kong, but those approvals do not establish a US access route.
Where can I buy thymosin alpha 1 peptide?
No place to buy it is established. FDA has not cleared thymosin alpha-1 for compounding, and the federal records do not give an access route in Arizona. Its only listed approved uses are national authorizations in Italy, India and Hong Kong.
How long can you take thymosin alpha 1?
The Italian Zadaxin label gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks from the first vaccination, repeated week 8 to week 12. No US-approved dose or duration exists.
References
Show all 8 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- Naing C, Ni H, Aung HH, Aye SN, Nikolova D, Poovorawan Y, et al. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database Syst Rev. 2026.
- World Anti-Doping Agency.